Back to results
US 2026/0085046 A1Published application
Dual Function Compounds For NADPH Oxidase Inhibition And Histone Deacetylase Inhibition
AssigneeTaiwanj Pharmaceuticals Co., Ltd.
InventorsOn LEE, Sheng-Chieh LIEN, Chia-Chueng CHEN
Life of this patent
Estimating the term…
Abstract
Disclosed are compounds of Formula (I) below and pharmaceutically acceptable salts thereof: in which each of variables MNox, L and ZBG is defined herein. Also disclosed is a method for treating a cancer with a compound of Formula (I) or a pharmaceutically acceptable salt thereof and a pharmaceutical composition containing the same.
Claims20
A compound of the following Formula (I):
- or a pharmaceutically acceptable salt thereof,
- wherein,
- ZBG is a hydroxamic acid group, an ortho-aminoanilide group or a derivative thereof;
- MNox is or comprises a binding moiety that binds to Nox, and has a formula derived from a compound having the following Formula (II):
- and
- L is a bond or a linker covalently coupling MNox and ZBG, and is covalently linked to any location on the MNox,
- wherein,
- A is an aminobenzene moiety, an ortho-dimethoxybenzene moiety, or a benzene moiety;
- B is a phenyl group substituted with one or more nitro, methyl, CF3, halogen, pyrrolidine, OR2, NR3R4, or SO2R3;
- R1 is H or C1-C10 alkyl;
- R2 is methyl, ethyl, n-propyl, or CF3;
- R3 is methyl, ethyl, n-propyl, or CF3;
- R4 is H;
- and
- X is OH or NH2.
12 more elements
A compound of the following Formula (IIb):
- wherein Y is halogen, methyl, CF3, OCH3, OCH2CH3, OCH2CH2CH3 or OCF3,
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.